1 April 2023 false Taxfiler 2024.6 14727683business:PrivateLimitedCompanyLtd2023-04-012024-03-31 147276832023-03-31 147276832023-04-012024-03-31 14727683business:AuditExemptWithAccountantsReport2023-04-012024-03-31 14727683business:FilletedAccounts2023-04-012024-03-31 147276832024-03-31 14727683business:Director12023-04-012024-03-31 14727683business:RegisteredOffice2023-04-012024-03-31 14727683core:WithinOneYear2024-03-31 14727683core:ShareCapitalcore:PreviouslyStatedAmount2024-03-31 14727683core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-03-31 14727683core:PreviouslyStatedAmount2024-03-31 14727683business:SmallEntities2023-04-012024-03-31 14727683countries:EnglandWales2023-04-012024-03-31 14727683business:OrdinaryShareClass12023-04-012024-03-31 iso4217:GBP xbrli:shares xbrli:pure
Company Registration No. 14727683 (England and Wales)
AMX Pharma Ltd Filleted accounts for the year ended 31 March 2024
AMX Pharma Ltd Filleted accounts Contents
Page
- 2 -
AMX Pharma Ltd Company Information for the year ended 31 March 2024
Director
Amina Aktar Miah
Company Number
14727683 (England and Wales)
Registered Office
Hawthorne House 17a Hawthorne Drive Leicester LE5 6DL United Kingdom
Accountants
YP Finance Hawthorne House 17A Hawthorne Drive Leicester Leicestershire LE5 6DL
- 3 -
AMX Pharma Ltd Statement of financial position as at 31 March 2024
2024 
Notes
£ 
Current assets
Cash at bank and in hand
61,792 
Creditors: amounts falling due within one year
(31,522)
Net current assets
30,270 
Net assets
30,270 
Capital and reserves
Called up share capital
100 
Profit and loss account
30,170 
Shareholders' funds
30,270 
For the year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 5 November 2024 and were signed on its behalf by
Amina Aktar Miah Director Company Registration No. 14727683
- 4 -
AMX Pharma Ltd Notes to the Accounts for the year ended 31 March 2024
1
Statutory information
AMX Pharma Ltd is a private company, limited by shares, registered in England and Wales, registration number 14727683. The registered office is Hawthorne House, 17a Hawthorne Drive, Leicester, LE5 6DL, United Kingdom.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Deferred taxation
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the company's accounts. Deferred tax is provided in full on timing differences which result in an obligation to pay more (or less) tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.
4
Creditors: amounts falling due within one year
2024 
£ 
Taxes and social security
8,596 
Other creditors
22,106 
Accruals
820 
31,522 
5
Share capital
2024 
£ 
Allotted, called up and fully paid:
100 Ordinary shares of £1 each
100 
Shares issued during the period:
100 Ordinary shares of £1 each
100 
- 5 -
AMX Pharma Ltd Notes to the Accounts for the year ended 31 March 2024
6
Average number of employees
During the year the average number of employees was 1.
- 6 -